Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-25

Clinical Trial Update: Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy [Phase 3]

View source ↗

Summary

Phase 3 trial of Xyrem (sodium oxybate) for narcolepsy has been completed. Results were posted on November 25, 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xyrem (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25